AI-generated summary
The authors retrospectively reviewed 30 patients with early-stage oral cavity or oropharyngeal squamous cell carcinoma treated with PHOTOFRIN-mediated photodynamic therapy, including patients not suited to or who had failed conventional treatment. They report complete remission in 24 of 30 patients (80%), with follow-up of 3 to 144 months, and recurrence in six partial responders. The retrospective design and limited follow-up are limits the abstract states.
- Participants
- 30
- Who or what was studied
- Patients with Tis-T2N0M0 squamous cell carcinoma of the oral cavity or oropharynx, including those not amenable to or who had failed conventional head and neck cancer treatment
- Wavelengths
- 630 nm
- Limits stated in the abstract
- This was a retrospective study of 30 patients, so the findings are not from a controlled design.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.